Anti-arthritic activity of ferulic acid in complete Freund’s adjuvant (CFA)-induced arthritis in rats: JAK2 inhibition

Inflammopharmacology - Tập 28 - Trang 463-473 - 2019
Lijuan Zhu1, Zhenshan Zhang1, Nannan Xia1, Weifeng Zhang1, Yanlin Wei1, Jiashu Huang1, Zhijuan Ren1, Feilong Meng1, Lei Yang1
1Department of Rheumatology and Immunology, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, China

Tóm tắt

Ferulic acid (FA), a hydroxycinnamic acid, is an organic compound found in several plant species. Previous studies have shown that FA contains anti-inflammatory and anti-arthritic properties. This study aimed to investigate the anti-arthritic activity and possible mechanism(s) of action of FA in complete Freund’s adjuvant (CFA)-induced arthritis. The progression of rheumatoid arthritis (RA) involves the activation of the Janus kinase-signal transducer and activator of transcription (JAK/STAT) pathway by proinflammatory cytokines. Molecular docking of FA showed promising Janus kinase 2 (JAK2) inhibition with a docking score of − 6.7, which is comparable with that of ruxolitinib, a standard inhibitor. However, in vitro JAK2 inhibition assay showed a half maximal inhibitory concentration (IC50) of 6.67 ± 0.88 µg/ml. Both doses of FA (25 and 50 mg/kg) significantly attenuated primary (volume of paw edema) and secondary lesions. CFA-induced arthritic rats showed a significant decrease in body weight, A/G ratio, and Hb but showed a greater arthritic index, ESR levels, and percentage of lymphocytes. These alterations were significantly reduced in rats treated with FA and prednisolone. FA also reversed changes to biochemical parameters and inflammatory markers, such as C-reactive protein (CRP) and rhematoid factor (RF). Additionally, we found CFA-induced arthritis triggered the secretion of TNF- α, increased JAK2 levels, and reduced TGF-β levels in tissue homogenates. However, in rats treated with FA, such alterations significantly improved. Thus, our results reveal that FA contains anti-arthritic activity, which is possibly mediated by the inhibition of the JAK/STAT pathway.

Tài liệu tham khảo

Andersen ML, Santos EHR, Seabra MDLV, da Silva AAB, Tufik S (2004) Evaluation of acute and chronic treatments with Harpagophytum procumbens on Freund's adjuvant-induced arthritis in rats. J Ethnopharm 91(2–3):325–330 Argiles JM, Lopez-Soriano FJ (2002) Catabolic proinflammatory cytokines. Curr Opin Clin Nutr Metab Care 1:245–251 Bansod S, Kagathara VG, Pujari RR, Patel VB, Ardeshna H (2011) Therapeutic effect of a poly-herbal preparation on adjuvant induced arthritis in wistar rats. Int J Pharm Pharm Sci 3(2):186–192 Bolling BW, Ji LL, Lee C, Parkin KL (2011) Dietary supplementation of ferulic acid and ferulic acid ethyl ester induces quinone reductase and glutathione-S-transferase in rats. Food Chem 124:1–6 Boyce EG (2006) Rheumatoid arthritis. In: Herfindal ET, Gourley DR (eds) Textbook of therapeutics: drugs and disease management, 8th edn. Williams & Wilkins, Baltimore Bright JJ, Sriram S (1998) TGF-β INHIBITS IL-12-induced activation of Jak-STAT pathway in T lymphocytes. J Immunol 161(4):1772–1777 Chantry D, Turner M, Abney E, Feldmann M (1989) Modulation of cytokine production by TGF-β1. J Immunol 142:4295 Cunha FV, Gomes Bde S, Neto Bde S, Ferreira AR, de Sousa DP, de Carvalho e Martins MC, Oliveira FA (2015) Ferulic acid ethyl ester diminished Complete Freund's ADJUVANT-induced incapacitation through antioxidant and anti-inflammatory activity. Naunyn-Schmiedeberg's Arch Pharmacol 389(1):117–130 Durai M, Kim HR, Moudgil KD (2004) The regulatory C-terminal determinants within mycobacterial heat shock protein 65 are cryptic and cross-reactive with the dominant self homologs: implications for the pathogenesis of autoimmune arthritis. J Immunol 173(1):181–188 Fox FE, Capocasale RJ, Ford HC, Lamb RJ, Moore JS, Nowell PC (1992) Transforming growth factor-β inhibits human T cell proliferation through multiple targets. Lymphokine Cytokine Res 11:299–305 Gomes A, Bhattacharya S, Chakraborty M, Bhattacharjee P, Mishra R, Gomes A (2010) Anti-arthritic activity of Indian monocellate cobra (Naja kaouthia) venom on adjuvant induced arthritis. Toxicon 55:670–673 Guo D, Dunbar JD, Yang CH, Pfeffer LM, Donner DB (1998) Induction of Jak/STAT signaling by activation of the type 1 TNF receptor. J Immunol 160(6):2742–2750 Hassanzadeh P, Arbabi E, Atyabi F, Dinarvand R (2017) Ferulic acid exhibits antiepileptogenic effect and prevents oxidative stress and cognitive impairment in the kindling model of epilepsy. Life Sci 179:9–14 Heim MH (1999) The JAK-STAT pathway: signaling from the receptor to nucleus. J Recept Signal Trans Res 19:75–120 Islam S, Yoshida H, Matsuki N, Ono K, Nagasaka R, Ushio H, Guo Y, Hiramatsu T, Hosoya T, Murata T, Hori M, Ozaki H (2009) Antioxidant, free radical–scavenging, and NF-κB–inhibitory activities of phytosteryl ferulates: structure–activity studies. J Pharmacol Sci 111:328–337 Jones MG, Shipley ME, Hearn JP, Hay FC (1990) Specificity of rheumatoid factors in relation to the disease state in rheumatoid arthritis. Ann Rheum Dis 49:757–762 Kaur S, Kaira S, Kaushal S (2014) Systematic review of tofacitinib: a new drug for the management of rheumatoid arthritis. Clin Ther 36:1074–1086 Kim W, Park S, Choi C, Kim YR, Park I, Seo C, Youn D, Shin W, Lee Y, Choi D, Kim M, Lee H, Kim S (2016) Evaluation of anti-inflammatory potential of the new Ganghwaljetongyeum on adjuvant-induced inflammatory arthritis in rats. Evid Based Complement Altern Med 2016:1–10 Kuruvilla AP, Shah R, Hochwald GM, Liggitt HD, Palladino MA, Thorbecke GJ (1991) Protective effect of TGF β1 in experimental autoimmune diseases in mice. Proc Natl Acad Sci 88:2918–2921 Lagunin A, Zakharov A, Filimonov D, Poroikov V (2011) QSAR modelling of rat acute toxicity on the basis of PASS prediction. Mol Inform 30:241–250 Malemud CJ (2009) Recent advances in neutralizing the IL-6 pathway in arthritis. Open Access Rheumatol 1:133–150 Malemud CJ (2018) The role of the JAK/STAT signal pathway in rheumatoid arthritis. Ther Adv Musculoskel Dis 10(5–6):117–127 Mancuso C, Santangelo R (2014) Ferulic acid: Pharmacological and toxicological aspects. Food Chem Toxicol 65:185–195 McInnes IB, Schett J (2011) The pathogenesis of rheumatoid arthritis. N Engl J Med 365:2205–2219 Mowat AG (1971) Hematologic abnormalities in Rheumatoid arthritis. Sem Arthr Rheum 1(3):195–219 Nell VP, Machold KP, Stamm TA, Eberl G, Heinzl H, Uffmann M, Smolen JS, Steiner G (2005) Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis. Ann Rheum Dis 64(12):1731–1736 Nielen MM, van Schaardenburg D, Reesink HW, Twisk JWR, van de Stadt RJ, van der Horst-Bruinsma IE, de Koning MH, Habibuw MR, Dijkmans BA (2006) Simultaneous development of acute phase response and autoantibodies in preclinical rheumatoid arthritis. Ann Rheum Dis 65:535–537 Ohori M (2008) Erk inhibitors as a potential new therapy for rheumatoid arthritis. Drug News Perspect 21:245–250 Ou S, Kwok KC (2004) Ferulic acid: pharmaceutical functions, preparation and applications in food. J Sci Food Agric 84:1261–1269 Panneerselvam L, Subbiah K, Arumugam A, Senapathy JG (2013) Ferulic acid modulates fluoride-induced oxidative hepatotoxicity in male Wistar rats. Biol Trace Elem Res 151:85–91 Patel MG, Pundarikakshudu K (2016) Anti-arthritic activity of a classical Ayurvedic formulation Vatari Guggulu in rats. J Tradit Complement Med 6(4):389–394 Patel SS, Shah PV (2013) Evaluation of anti-inflammatory potential of the multidrug herbomineral formulation in male Wistar rats against rheumatoid arthritis. J Ayurveda Integr Med 4(2):86–93 Pearson CM (1956) Development of arthritis, periarthritis and periostitis in rats given adjuvants. Exp Biol Med 91(1):95–101 Poroikov VV, Filimonov DA, Ihlenfeldt WD, Gloriozova TA, Lagunin AA, Borodina YV, Stepanchikova AV, Nicklaus MC (2003) PASS biological activity spectrum predictions in the enhanced open NCI database browser. J Chem Inf Comput Sci 43:228–236 Rall LC, Roubenoff R (2004) Rheumatoid cachexia: metabolic abnormalities, mechanisms and interventions. Rheumatology 10:1219–1223 Scott P (1993) IL-12: initiation cytokine for cell-mediated immunity. Science 260:496–497 Shelton DL, Zeller J, Ho WH, Pons J, Rosenthal A (2005) Nerve growth factor mediates hyperalgesia and cachexia in auto-immune arthritis. Pain 116:8–16 Sultana R (2012) Ferulic acid ethyl ester as a potential therapy in neurodegenerative disorders. Biochim Biophys Acta 1822:748–752 Sultana R, Ravagna A, Mohmmad-Abdul H, Calabrese V, Butterfield DA (2005) Ferulic acid ethyl ester protects neurons against amyloid beta-peptide(1–42)-induced oxidative stress and neurotoxicity: Relationship to antioxidant activity. J Eurochem 92:749–758 Tada Y, Tayama K, Aoki N (1999) Acute oral toxicity of ferulic acid, natural food additive, in rats. Ann Rep Tokyo Metr Lab PH 50:311–313 Thyagaraju BM (2008) Ferulic acid supplements abrogate oxidative impairments in liver and testis in the streptozotocin-diabetic rat. Zool Sci 25:854–860 Vetal S, Bodhankar SL, Mohan V, Thakurdesai PA (2013) Anti-inflammatory and anti-arthritic activity of type-A procyanidine polyphenols from bark of Cinnamomum zeylanicum in rats. Food Sci Hum Wellness 2:59–67 Vogel HG, Vogel WH (eds) (2002) Drug discovery and evaluation pharmacological assays, 2nd edn. Springer, Berlin Wajant H, Pfizernmaier K, Scheurich P (2003) Tumor necrosis factor signaling. Cell Death Differ 10:45–65 Wang BH, Ou-Yang JP (2005) Pharmacological actions of sodium ferulate in cardiovascular system. Cardiovasc Drug Rev 23:161–172 Zeni ALB, Camargo A, Dalmagro AP (2017) Ferulic acid reverses depression-like behavior and oxidative stress induced by chronic corticosterone treatment in mice. Steroids 125:131–136 Zhang L, Al-Suwayeh SA, Hsiehc P, Fang J (2010) A comparison of skin delivery of ferulic acid and its derivatives: evaluation of their efficacy and safety. Int J Pharm 399:44–51 Zhang S, Wang P, Zhao P, Wang D, Zhang Y, Wang J, Chen L, Guo W, Gao H, Jiao Y (2018) Pretreatment of ferulic acid attenuates inflammation and oxidative stress in a rat model of lipopolysaccharide-induced acute respiratory distress syndrome. Int J Immunopathol Pharmacol 31:1–9